CN1289061C - 用于预防和治疗臭汗症的药剂 - Google Patents

用于预防和治疗臭汗症的药剂 Download PDF

Info

Publication number
CN1289061C
CN1289061C CNB028185765A CN02818576A CN1289061C CN 1289061 C CN1289061 C CN 1289061C CN B028185765 A CNB028185765 A CN B028185765A CN 02818576 A CN02818576 A CN 02818576A CN 1289061 C CN1289061 C CN 1289061C
Authority
CN
China
Prior art keywords
botulinum toxin
body odor
odor
skin
sweat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028185765A
Other languages
English (en)
Chinese (zh)
Other versions
CN1556693A (zh
Inventor
马克·海克曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CN1556693A publication Critical patent/CN1556693A/zh
Application granted granted Critical
Publication of CN1289061C publication Critical patent/CN1289061C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893Botulinum neurotoxin (3.4.24.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB028185765A 2001-09-21 2002-09-23 用于预防和治疗臭汗症的药剂 Expired - Fee Related CN1289061C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146647.1 2001-09-21
DE10146647A DE10146647A1 (de) 2001-09-21 2001-09-21 Arzneimittel zur Prophylaxe und Therapie von Bromhidrosis

Publications (2)

Publication Number Publication Date
CN1556693A CN1556693A (zh) 2004-12-22
CN1289061C true CN1289061C (zh) 2006-12-13

Family

ID=7699852

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028185765A Expired - Fee Related CN1289061C (zh) 2001-09-21 2002-09-23 用于预防和治疗臭汗症的药剂

Country Status (16)

Country Link
US (1) US20050036966A1 (enExample)
EP (2) EP1427385B1 (enExample)
JP (1) JP4966478B2 (enExample)
KR (1) KR100796243B1 (enExample)
CN (1) CN1289061C (enExample)
AU (1) AU2002349268B2 (enExample)
CA (1) CA2461117C (enExample)
DE (1) DE10146647A1 (enExample)
EA (2) EA011988B1 (enExample)
HU (1) HU230398B1 (enExample)
IL (2) IL160875A0 (enExample)
MX (1) MXPA04002614A (enExample)
PL (1) PL209639B1 (enExample)
UA (1) UA78718C2 (enExample)
WO (1) WO2003026602A2 (enExample)
ZA (1) ZA200402123B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113349A1 (en) 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods
US7288259B2 (en) 2002-08-19 2007-10-30 Ira Sanders Treatment of holocrine gland dysfunction with clostridia neurotoxins
BRPI0408114A (pt) 2003-03-06 2006-03-01 Botulinum Toxin Res Ass Inc tratamento de calázio crÈnico e hordéolo com toxina botulinìca
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders
BRPI0608249A2 (pt) * 2005-03-03 2009-12-08 Revance Therapeutics Inc formulação, método para aplicação tópica e kit para distribuição transdérmica de toxina botulìnica
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
EP2494958A1 (en) 2006-12-01 2012-09-05 Anterios, Inc. Amphiphilic Entity Nanoparticles
KR20160130519A (ko) * 2008-06-26 2016-11-11 안테리오스, 인코퍼레이티드 경피 운반
US8454975B1 (en) * 2010-01-11 2013-06-04 Elizabeth VanderVeer Method for enhancing skin appearance
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents
US11191819B2 (en) 2018-08-28 2021-12-07 Ira Sanders Skin therapeutics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19852981A1 (de) * 1998-11-17 2000-05-18 Martin Schmidt Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen
US20020086036A1 (en) * 2000-12-05 2002-07-04 Allergan Sales, Inc. Methods for treating hyperhidrosis
US20030113349A1 (en) * 2001-12-18 2003-06-19 Coleman William P. Topically applied clostridium botulinum toxin compositions and treatment methods

Also Published As

Publication number Publication date
EP2987483B1 (de) 2020-12-02
DE10146647A1 (de) 2003-04-24
EA008146B1 (ru) 2007-04-27
HUP0401913A2 (hu) 2005-01-28
WO2003026602A3 (de) 2003-08-28
JP2005507888A (ja) 2005-03-24
CN1556693A (zh) 2004-12-22
ZA200402123B (en) 2004-10-04
PL373528A1 (en) 2005-09-05
EA200601238A1 (ru) 2007-06-29
PL209639B1 (pl) 2011-09-30
UA78718C2 (en) 2007-04-25
EP2987483A1 (de) 2016-02-24
JP4966478B2 (ja) 2012-07-04
AU2002349268B2 (en) 2007-12-13
EP1427385B1 (de) 2015-09-23
US20050036966A1 (en) 2005-02-17
IL160875A0 (en) 2004-08-31
MXPA04002614A (es) 2005-02-17
EP1427385A2 (de) 2004-06-16
WO2003026602A2 (de) 2003-04-03
IL160875A (en) 2010-11-30
EA011988B1 (ru) 2009-06-30
KR100796243B1 (ko) 2008-01-21
KR20040048895A (ko) 2004-06-10
EA200400436A1 (ru) 2007-02-27
CA2461117A1 (en) 2003-04-03
CA2461117C (en) 2009-12-08
HUP0401913A3 (en) 2008-02-28
HU230398B1 (hu) 2016-04-28

Similar Documents

Publication Publication Date Title
Benohanian Antiperspirants and deodorants
CN1289061C (zh) 用于预防和治疗臭汗症的药剂
Indurkar et al. Effect of ozonated oil and chlorhexidine gel on plaque induced gingivitis: A randomized control clinical trial
US20060110439A1 (en) Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds
JPH11322561A (ja) 微生物付着を低減する薬剤としての少なくとも1種のヒドロキシスチルベンの用途
Joseph et al. Tongue pathology
Ballantyne et al. Dermal sensitizing potential of glutaraldehyde: a review and recent observations
KR101914500B1 (ko) 체취 억제용 화장료 조성물
Makmuriana et al. Chlorhexidine and honey: Mouthwash liquids in reducing halitosis of stroke patients
JP7292272B2 (ja) 体臭の処置又は予防に用いるチロスリシン及びそのための製剤
CN109289042A (zh) 一种除臭液及其制备方法和应用
JP2000290163A (ja) 保湿クリーム
Pessemier et al. Underarm body odor, the microbiome, and probiotic treatment
KR102847522B1 (ko) 오존화 오일을 포함하는 미백용 기능성 패치
RU2819716C1 (ru) Способ лечения себорейного дерматита волосистой части головы
JPS5883612A (ja) 防臭防汗用塗布剤
KR20210042616A (ko) 왁스형 클렌저
CN1297250C (zh) 一种消除人体脚臭、腋臭的外用药粉
Ramchiary et al. Effect of aroma gargle and mouthwash on halitosis and xerostomia-A systematic review
Raab Aromatherapy in the intensive care unit: An overview
Ravindra et al. Olfactory Diagnosis in Skin
CN1875942A (zh) 抑汗、除臭外用喷雾剂配方
JP2022183707A (ja) 皮膚常在菌叢制御用組成物
Morgan The Serpent's Tooth in Formaldehyd

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: ALEGAN CO.,LTD.

Free format text: FORMER OWNER: MAKEHAIKEMAN

Effective date: 20060127

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20060127

Address after: American California

Applicant after: ALLERGAN, Inc.

Address before: German Bochim

Applicant before: Heckmann Marc

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20061213

Termination date: 20210923

CF01 Termination of patent right due to non-payment of annual fee